Signature MD, Inc. – Trademark Portfolio
Entity Type: 03
Signature MD, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 10 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SIGNATUREMD, HUMAN. HEALTH. CARE., SIGNATUREMD HUMAN. HEALTH. CARE., and S SIGNATUREMD HUMAN. HEALTH. CARE.. The owner is based in Santa Monica, CA.
2633 Lincoln Blvd, #838
Santa Monica, CA 90405
Showing of trademarks Trademarks
Trademark Classifications
Signature MD, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Signature MD, Inc. have?
Signature MD, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 7 cancelled.
What trademark classes does Signature MD, Inc. file in?
Signature MD, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Signature MD, Inc.'s most well-known trademarks?
Signature MD, Inc.'s registered trademark portfolio includes well-known marks such as SIGNATUREMD, HUMAN. HEALTH. CARE., SIGNATUREMD HUMAN. HEALTH. CARE., and S SIGNATUREMD HUMAN. HEALTH. CARE.. These are among 4 currently registered trademarks in the portfolio.
What is Signature MD, Inc.'s trademark registration success rate?
Signature MD, Inc. has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.